Sponsor of the Day:
Jerkmate
https://www.statnews.com/2026/04/13/biotech-news-gsk-advacing-ovarian-cancer-drug-mo-rez/
Revolution Medicines, GSK, Allogene: Readout Newsletter
Apr 13, 2026 - Today's biotech news includes Revolution Medicines 'unprecedented' cancer trial data, Allogene's off-the-shelf CAR-T, and more
revolution medicinesreadout newslettergskallogene
https://endpoints.news/revolution-medicines-leads-latest-wave-of-stock-offerings-totaling-1-5b/
Revolution Medicines leads latest wave of stock offerings, totaling $1.5B
Revolution Medicines anchored Monday's offering surge, while Spyre Therapeutics and Allogene Therapeutics also joined in. The trio is planning to raise almost...
revolution medicinesleads latest1 5bwavestock
https://www.statnews.com/2026/04/21/aacr-2026-pancreatic-cancer-revolution-medicines-future/
Revolution Medicines previews 'novel class' of cancer treatments | STAT
Apr 22, 2026 - A company that is changing the outlook on pancreatic cancer has more promising data for treatments near-term and for a generation beyond.
revolution medicinescancer treatmentspreviewsnovelclass
https://online.nikkei-cnbc.co.jp/vod/64906
REVOLUTION MEDICINES INC (RVMD) / REPLIMUNE GROUP (REPL) - ジム・クレイマーのMAD DASH（日本語字幕版） | 日経CNBC online
米CNBCの人気司会者であり投資家のジム・クレーマーが、取引開始直前に株価材料を解説する。...
revolution medicinesreplimune groupinconline